(Q37383575)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19187414%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

review article

1 reference

title

Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19187414%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19187414%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Frank J Molnar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19187414%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Malcolm Man-Son-Hing

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19187414%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

29 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19187414%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Geriatrics Society

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19187414%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19187414%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19187414%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

536-546

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19187414%20AND%20SRC:MED&resulttype=core&format=json

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2008.02122.X

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2008.02122.X

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2008.02122.X

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2008.02122.X

10.1111/J.1532-5415.2008.02122.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19187414%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference